Top Page
Cohort plc
(LSE:CHRT)
Cohort plc (CHRT) vs. iShares MSCI United Kingdom ETF (EWC)
Cohort plc Business Overview & Revenue Model
Cohort plc Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 270.04M | 270.04M | 202.53M | 182.71M | 137.76M | 143.31M |
| Gross Profit | 78.81M | 90.42M | 76.27M | 64.86M | 56.60M | 53.36M |
| EBITDA | 32.48M | 35.57M | 29.25M | 22.13M | 20.78M | 20.34M |
| Net Income | 19.25M | 19.25M | 15.32M | 11.36M | 9.20M | 5.46M |
Balance Sheet | ||||||
| Total Assets | 396.58M | 396.58M | 252.50M | 210.69M | 203.17M | 190.88M |
| Cash, Cash Equivalents and Short-Term Investments | 74.65M | 74.65M | 55.16M | 41.45M | 40.37M | 32.29M |
| Total Debt | 78.88M | 78.88M | 40.51M | 34.98M | 39.52M | 37.38M |
| Total Liabilities | 236.49M | 236.49M | 142.66M | 110.91M | 113.98M | 105.83M |
| Stockholders Equity | 158.61M | 158.61M | 108.67M | 97.02M | 83.97M | 79.31M |
Cash Flow | ||||||
| Free Cash Flow | 39.13M | 38.00M | 16.36M | 11.29M | 17.52M | 14.97M |
| Operating Cash Flow | 52.31M | 51.18M | 23.02M | 16.52M | 19.52M | 16.22M |
| Investing Cash Flow | -94.77M | -93.65M | -6.16M | -6.11M | -2.37M | -2.54M |
| Financing Cash Flow | 46.18M | 46.18M | -16.92M | -10.57M | -8.70M | -1.55M |
Cohort plc Technical Analysis
Cohort plc Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.54B | 39.43 | ― | 1.45% | ― | ― | |
66 Neutral | $52.78B | 27.46 | 17.59% | 1.89% | 11.60% | 8.03% | |
66 Neutral | £1.70B | 69.38 | 18.87% | 0.60% | 14.88% | 45.73% | |
66 Neutral | £570.89M | 112.60 | 4.18% | 1.00% | 14.69% | ― | |
63 Neutral | £592.27M | 28.76 | 14.40% | 1.31% | 33.33% | 19.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | £2.53B | -13.93 | -23.92% | 1.99% | 1.02% | -240.44% |
Cohort plc Corporate Events
Cohort plc, an independent technology group listed on AIM, announced that its issued share capital as of October 31, 2025, consists of 46,915,549 ordinary shares, each carrying one vote. This figure is significant for shareholders as it serves as the denominator for calculating their interests under the FCA’s Disclosure Guidance and Transparency Rules. The announcement underscores Cohort’s commitment to transparency and regulatory compliance, which is crucial for maintaining investor confidence and market integrity.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1467.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that Simon Walther, the Finance Director, exercised options over 1,015 ordinary shares at a price of 532 pence per share under the Cohort plc Savings Related Share Option Scheme. This transaction increases Mr. Walther’s beneficial interest to 150,818 shares, representing 0.32% of the company’s total issued share capital. This move reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting stakeholder confidence and market perception.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1467.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, have purchased shares under the company’s Share Incentive Plan. This transaction reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially strengthening stakeholder confidence in Cohort’s leadership and strategic direction.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1469.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that dividends received by its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, were automatically reinvested into company shares. This transaction resulted in Thomis holding 0.40% and Walther holding 0.32% of the company’s total issued share capital. The reinvestment reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially strengthening investor confidence in the company’s governance and financial strategies.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1557.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc’s subsidiary, MASS, has secured a £15.7 million contract to provide airborne countermeasures and associated services to a UK defence prime contractor for an international client. This contract, alongside recent wins totaling £60 million, strengthens Cohort’s revenue visibility and underscores MASS’s leading position in the spectrum warfare sector.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1557.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc, an AIM-listed independent technology group, announced that its issued share capital consists of 46,845,936 ordinary shares, each carrying one vote. This update is in accordance with the FCA’s Disclosure Guidance and Transparency Rule. The company does not hold any shares in treasury, and this figure serves as a denominator for shareholders to determine their interest in the company’s shares, impacting their notification requirements under the relevant rules.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1503.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced the successful passing of all resolutions at its recent Annual General Meeting. This outcome reflects strong shareholder support and is likely to bolster the company’s strategic initiatives and operational stability. The approval of resolutions, including those related to share plans and director re-elections, underscores confidence in the company’s leadership and future direction.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1478.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc reported record financial results for FY2025, with significant achievements in revenue, operating profit, and order intake. The company maintains a robust order book and anticipates continued growth in FY2026, despite a slower start in the first half. The acquisition of EM Solutions has positively contributed to the group’s performance, and ongoing geopolitical tensions are expected to drive further investment in defense, supporting Cohort’s organic and acquisition-driven growth strategy.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1478.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced the grant of share options under its 2016 Savings Related Share Option Scheme to Simon Walther, the Finance Director. The options, which are part of a three-year savings contract, were offered at a 20% discounted exercise price based on the share price as of August 21, 2025. This move is part of Cohort’s strategy to incentivize its leadership team and align their interests with those of the company’s stakeholders, potentially impacting the company’s operational focus and market positioning.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1445.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that its Chief Executive, Andrew Thomis, will be presenting an introduction to the company at MelloMonday on September 15, 2025, via a Zoom Webinar. This presentation aims to engage with potential investors and stakeholders, highlighting the company’s strategic initiatives and market positioning in the defense sector.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1335.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced changes in director shareholdings following the vesting of the Executive Long Term Incentive Plan 2021 share awards. The vested shares were transferred to executive directors at no cost, with a portion sold to cover tax and National Insurance liabilities. The remaining shares are subject to a two-year holding period. The vesting was based on performance conditions related to organic and total growth targets, which were exceeded. This announcement highlights Cohort’s strong performance and commitment to rewarding its executives, potentially impacting its market positioning positively.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1335.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced changes in director shareholdings, specifically the vesting and transfer of share awards to Andrew Thomis, the Chief Executive. This transaction highlights the company’s ongoing commitment to its executive compensation strategy, potentially impacting stakeholder perceptions and reinforcing its market position.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1754.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced its total voting rights as of 31 August 2025, with an issued share capital consisting of 46,805,622 ordinary shares, each carrying one vote. This update is in accordance with the FCA’s Disclosure Guidance and Transparency Rule, providing shareholders with the necessary information to calculate their interests in the company’s shares. This announcement ensures transparency and compliance with regulatory requirements, maintaining Cohort’s commitment to clear communication with its stakeholders.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1754.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced the release of its Annual Report and Accounts for the year ending April 30, 2025, along with the Notice of its Annual General Meeting (AGM), which will be held on September 25, 2025, in London. This announcement is significant for shareholders and stakeholders as it provides insights into the company’s financial performance and strategic direction, impacting its operations and positioning within the defense and related markets.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1754.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced changes in director shareholdings, specifically the transfer of vested shares to Simon Walther, the Finance Director. This transfer, part of the 2013 Restricted Share Scheme, highlights the company’s ongoing commitment to aligning management interests with shareholder value. The transaction reflects a structured approach to executive compensation, potentially impacting stakeholder perceptions of the company’s governance and financial strategies.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced the grant of Long-Term Incentive Plan (LTIP) awards to its Chief Executive Officer, Andrew Thomis, and Finance Director, Simon Walther. These awards, comprising ordinary shares, are performance-related and will vest in August 2028, contingent on achieving growth targets. This move is part of Cohort’s strategy to align executive incentives with company performance, potentially enhancing its market position and stakeholder value.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.